OTC: TLTFF - Theralase Technologies Inc.

Yield per half year: +7.69%
Sector: Healthcare

Share chart Theralase Technologies Inc.


Theralase Technologies Inc., a clinical stage pharmaceutical company, engages in the research and development of photo dynamic compounds (PDCs) and their associated drug formulations to treat cancers, bacteria, and viruses in Canada, the United States, and internationally. It also designs, develops, manufactures, and markets patented and proprietary super-pulsed laser technology for the healing of chronic knee pain, as well as for off-label use to heal various nerve, muscle, and joint conditions.

More details
In addition, the company develops TLD-1433, which is in Phase II for the treatment of Bacillus Calmette Guérin - Unresponsive Carcinoma In-Situ non-muscle invasive bladder cancer. Further, its product candidates include TLC-2000, a superpulsed and visible red laser technology accelerates healing by reducing pain and inflammation while staying below the Maximal Permissible Exposure limit for tissue, as well as related accessories. Additionally, it provides controller-less cool laser therapy systems comprising TLC-900, TLC-300, and TLC-100. The company has research agreements with the University of Manitoba Medical Microbiology department for the development of a coronavirus vaccine and therapy; and the National Microbiology Laboratory and Public Health Agency of Canada for the research and development of a Canadian-based SARS-CoV-2 vaccine. It sells its products to healthcare practitioners. The company was incorporated in 1989 and is based in Toronto, Canada.

Цена ао 0.13
Выручка 0.0013
EBITDA -0.0093
P/S 62.43
P/BV 4.34
Сайт https://www.theralase.com
Число акций ао 0.22846 млрд
Change price per day: -6.67% (0.15)
Change price per week: 0% (0.14)
Change price per month: +16.67% (0.12)
Change price per 3 month: -6.67% (0.15)
Change price per half year: +7.69% (0.13)
Change price per year: -33.33% (0.21)
Change price per year to date: 0% (0.14)

All parameters ⇨


Title Value Grade
P/S 62.43 1
P/BV 4.34 1
P/E 0 0


Title Value Grade
ROA, % -91.61 0
ROE, % -136.15 0


Title Value Grade
Div yield, % 0 0
DSI 0 0


Title Value Grade
Debt/EBITDA 0 10

Growth impulse

Title Value Grade
Profit growth, % -43.4 0
Share price growth, % 0 0
Dividend growth, % 0 0

Head Job title Payment Year of birth
Ms. Kristina Hachey CPA CFO & Director 191.2k
Dr. Arkady Mandel DSc., M.D., Ph.D. Chief Scientific Officer & Director 227.97k
Mr. Roger John Dumoulin-White B.Sc., P.Eng. President, CEO & Director 221.21k
Mr. David M. Groves B.A President of World Trade Division N/A
Dr. Terry Ruch DVM Equine Medical Consultant N/A

Address: Canada, Toronto. ON MB G, 41 Hollinger Road - open in Google maps, open in Yandex maps
Website: https://www.theralase.com